Global Cataracts Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

Cataracts Market Analysis

Cataracts, characterized by the clouding of the eye's natural lens, remain a leading cause of vision impairment globally. Such condition typically progresses with age, but can also result from trauma, certain medications, or genetic factors. Recent developments in cataract treatment focus on advanced intraocular lenses (IOLs) and improved surgical techniques. For instance, Alcon's introduction of the AcrySof IQ Vivity IOL in January 2022 represents a significant advancement, utilizing wavefront-shaping technology to enhance visual clarity and correct presbyopia. Similarly, the integration of femtosecond laser technology into cataract surgery has refined precision and safety, reducing recovery times and improving outcomes. Additionally, ongoing research is exploring new pharmacological treatments to prevent or slow cataract formation, potentially offering non-surgical alternatives in the future. These innovations underscore the dynamic evolution of cataract management, aiming to enhance visual outcomes and quality of life for patients worldwide.

Cataracts Market Size

The global Cataracts market size was valued at USD 5.28 billion in 2023 and is projected to reach USD 8.41 billion by 2031, with a CAGR of 6.0% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Cataracts Market Trends

“Rise in Premium Intraocular Lenses (IOLs)”

The cataract market is experiencing significant growth, driven by the increasing prevalence of age-related cataracts and advancements in surgical technologies. A prominent trend is the rise in premium intraocular lenses (IOLs), which offer enhanced visual outcomes compared to traditional options. For instance, the TECNIS Symfony IOL by Johnson & Johnson MedTech represents a breakthrough in cataract treatment, providing extended depth of focus and improved night vision, addressing common limitations of standard IOLs. This trend reflects a broader shift towards personalized and advanced cataract treatments that cater to varying patient needs. The integration of cutting-edge technology, such as advanced imaging systems and minimally invasive surgical techniques, further enhances the precision and effectiveness of cataract surgery. Such trend not only improves patient satisfaction but also drives market growth as healthcare providers adopt these innovative solutions to meet the evolving demands of cataract management.

Report Scope and Cataracts Market Segmentation   

Cataracts Market Definition

Cataracts are a common eye condition characterized by the clouding of the eye's natural lens, which leads to a decrease in vision clarity. The lens, normally transparent, becomes opaque or cloudy, obstructing light from passing through to the retina. This clouding can cause blurred vision, difficulty seeing at night, sensitivity to glare, and color distortion. Cataracts often develop gradually and are typically associated with aging, though they can also result from other factors such as trauma, certain medications, or genetic conditions. Treatment usually involves surgical removal of the cloudy lens and replacement with an artificial intraocular lens (IOL).

Cataracts Market Dynamics

Drivers

• Rising Geriatric Population

The global aging population is a major driver of the cataracts market, given that cataracts predominantly affect older adults. According to the World Health Organization (WHO), the number of people aged 60 and over is projected to reach 2.1 billion by 2050, up from 1.2 billion in 2019. This significant increase in the elderly population correlates with a higher incidence of cataracts, with about 10 million cataract surgeries performed globally each year. The rising number of elderly individuals is expected to further drive demand for cataract treatments, as age is the primary risk factor for this condition. As the population ages, the need for effective cataract management solutions, including advanced surgical techniques and innovative treatment options, will continue to grow, influencing the market's expansion.

• Rising Prevalence of Risk Factors

The rising prevalence of risk factors such as diabetes and obesity significantly drives the demand for cataract management solutions. Diabetes, which affects over 537 million adults globally as reported by the International Diabetes Federation (IDF) in 2021, is a major contributor to cataract formation due to its impact on blood sugar levels and subsequent damage to eye tissues. Additionally, obesity, a condition that has reached epidemic proportions with over 2.8 million deaths annually linked to obesity-related diseases, is associated with an increased risk of developing cataracts. As these risk factors become more prevalent, the need for cataract treatments and management solutions grows, driving the market for advanced surgical and pharmaceutical interventions.

Opportunities

• Innovative Treatment Modalities

Innovative treatment modalities are significantly expanding the cataracts market with advanced drug delivery systems and pharmacological therapies. Research into nanotechnology-based drug delivery is developing non-surgical options by targeting cataract-affected lenses with medications that may reverse or slow lens opacity. For instance, ongoing studies on N-acetylcarnosine eye drops show potential for reducing cataract progression. Additionally, sustained-release drug implants, such as those for corticosteroid delivery, promise long-term management of cataract-related inflammation. Such advancements offer new, non-invasive treatment alternatives, complementing traditional surgical methods. By providing innovative solutions that address cataract management in novel ways, these developments are broadening market opportunities and enhancing patient care options.

• Expansion of Specialized Cataract Surgery Centres

The expansion of specialized cataract surgery centres and eye care clinics in underserved regions offers substantial opportunities for market growth by enhancing the availability of high-quality cataract care. For instance, organizations such as VisionSpring have been instrumental in setting up eye care clinics in remote areas of India and Africa, addressing the critical need for accessible and specialized cataract treatments. These centres are designed to provide comprehensive and efficient cataract care, including advanced diagnostic tools and surgical techniques, which attract patients seeking targeted treatments. By increasing the presence of such facilities in regions with limited access to specialized eye care, the market can address unmet needs, improve patient outcomes, and foster growth by capturing the demand for quality cataract services.

Restraints/Challenges

Postoperative Complications

Postoperative complications are a notable challenge in cataract surgery, despite its generally high safety profile, impacting the global cataracts market. Complications such as infection, inflammation, and visual disturbances can adversely affect patient outcomes and satisfaction. For instance, endophthalmitis, a serious infection occurring inside the eye, is a rare but severe complication that can lead to vision loss if not promptly treated. Similarly, posterior capsule opacification (PCO), where the membrane behind the lens becomes cloudy, can impair vision even after successful surgery and may require additional procedures like YAG laser capsulotomy to restore clarity. Such complications poses as a significant market challenge, as they can affect patient trust in surgical procedures, increase healthcare costs, and necessitate ongoing advancements in both surgical techniques and postoperative care.

Material Limitations

The high costs associated with advanced cataract treatments, including premium intraocular lenses (IOLs) and cutting-edge surgical technologies, pose a significant barrier to market growth, particularly in low-income and emerging markets. For instance, premium IOLs, which offer enhanced visual outcomes and reduced reliance on corrective eyewear, can cost several thousand dollars per eye, making them inaccessible to many patients in developing regions. Such financial challenge limits the adoption of such advanced solutions and prevents a substantial portion of the population from benefiting from the latest innovations in cataract care. In countries with limited healthcare budgets and lower average incomes, such as those in parts of Africa and Southeast Asia, the high cost of these treatments further exacerbates disparities in access to quality eye care. As a result, the market faces constraints in these regions, where affordability remains a critical concern, impacting the overall expansion and reach of advanced cataract treatment options.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Cataracts Market Scope

The market is segmented on the basis of type, diagnosis, treatment, end-users, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Nuclear Cataract
• Cortical Cataract
• Posterior Subcapsular Cataract
• Congenital Cataracts
• Others

Diagnosis

• Visual Acuity Test
• Slit-Lamp Examination
• Retinal Exam
• Others

Treatment

• Surgery

End-Users

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel:

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Cataracts Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, diagnosis, treatment, end-users, and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the market primarily due to the concentration of major manufacturers, substantial investment in research and development, and significant healthcare expenditures. The region's advanced healthcare infrastructure and high levels of expertise among medical professionals further bolster its market dominance. Additionally, North America's robust innovation environment supports continuous advancements in product development and clinical practices.

The Asia-Pacific region has experienced notable growth in the global cataract market during the forecast period, driven by a rising prevalence of cataracts and other eye disorders. This growth is attributed to factors such as an aging population, increasing urbanization, and improved diagnostic and treatment facilities. Enhanced awareness and access to advanced ophthalmic care are further contributing to the expansion of the cataract market in this dynamic region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Cataracts Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Cataracts Market Leaders Operating in the Market Are:

• Alcon Management S. A. (Switzerland)
• AbbVie Inc. (U.S.)
• Bausch Health Companies Inc. (Canada)
• Merck & Co. Inc. (U.S.)
• Pfizer Inc. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Amorphex Therapeutics Holdings, Inc. (U.S.)
• Astellas Pharma Inc. (Japan)
• Bayer AG (Germany)
• Novartis AG (Switzerland)
• AstraZeneca (U.K.)
• Amgen Inc. (U.S.)
• Carl Zeiss AG (Germany)
• HumanOptics Holding AG (Germany)
• STAAR SURGICAL (U.S.)

Latest Developments in Cataracts Market

• In February 2024, Johnson & Johnson MedTech, a leading name in eye health, announced the launch of its TECNIS PureSee presbyopia-correcting lens in the EMEA region. The TECNIS PureSee IOL is distinguished by its innovative, purely refractive design, offering uninterrupted, high-quality vision with exceptional contrast and low-light performance. This advanced intraocular lens provides visual clarity comparable to a monofocal IOL, setting a new standard in presbyopia correction.
• In September 2024, Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced new innovations during the European Society of Cataract and Refractive Surgeons (ESCRS) Annual Meeting in Barcelona. Driven by the ARGOS Biometer and future Alcon diagnostic technologies, the newly available SMARTCataract DX digital planning solution is designed to power workflow efficiencies for practices.

SKU-53861